GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Animalcare Group PLC (LSE:ANCR) » Definitions » EV-to-EBIT

Animalcare Group (LSE:ANCR) EV-to-EBIT : 33.49 (As of May. 04, 2024)


View and export this data going back to 2008. Start your Free Trial

What is Animalcare Group EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Animalcare Group's Enterprise Value is £143.09 Mil. Animalcare Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was £4.27 Mil. Therefore, Animalcare Group's EV-to-EBIT for today is 33.49.

The historical rank and industry rank for Animalcare Group's EV-to-EBIT or its related term are showing as below:

LSE:ANCR' s EV-to-EBIT Range Over the Past 10 Years
Min: -141.14   Med: 17.52   Max: 461.47
Current: 33.48

During the past 13 years, the highest EV-to-EBIT of Animalcare Group was 461.47. The lowest was -141.14. And the median was 17.52.

LSE:ANCR's EV-to-EBIT is ranked worse than
76.01% of 667 companies
in the Drug Manufacturers industry
Industry Median: 17.86 vs LSE:ANCR: 33.48

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Animalcare Group's Enterprise Value for the quarter that ended in Dec. 2023 was £103.42 Mil. Animalcare Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was £4.27 Mil. Animalcare Group's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 4.13%.


Animalcare Group EV-to-EBIT Historical Data

The historical data trend for Animalcare Group's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Animalcare Group EV-to-EBIT Chart

Animalcare Group Annual Data
Trend Jun13 Jun14 Jun15 Jun16 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -124.15 187.04 152.76 47.59 24.20

Animalcare Group Semi-Annual Data
Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 152.76 - 47.59 - 24.20

Competitive Comparison of Animalcare Group's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Animalcare Group's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Animalcare Group's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Animalcare Group's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Animalcare Group's EV-to-EBIT falls into.



Animalcare Group EV-to-EBIT Calculation

Animalcare Group's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=143.089/4.273
=33.49

Animalcare Group's current Enterprise Value is £143.09 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Animalcare Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was £4.27 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Animalcare Group  (LSE:ANCR) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Animalcare Group's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=4.273/103.41743
=4.13 %

Animalcare Group's Enterprise Value for the quarter that ended in Dec. 2023 was £103.42 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Animalcare Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was £4.27 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Animalcare Group EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Animalcare Group's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Animalcare Group (LSE:ANCR) Business Description

Traded in Other Exchanges
Address
Monks Cross Drive, Moorside, York, GBR, YO32 9LB
Animalcare Group PLC is active in the healthcare division in the United Kingdom. It is a generic veterinary medicines company. The company mainly caters to veterinary professionals in the treatment of companion animals through a product line comprised of licensed veterinary medicines and companion animal identification products and services. Its only reportable segment is Pharmaceutical which includes the development and marketing of innovative pharmaceutical products. The company has a presence in Belgium, The Netherlands, Germany, Italy, Portugal, European Union - Other, Asia, Middle East Africa, Spain, the United Kingdom, and Other Countries of which Spain derives a majority of revenue to the company.

Animalcare Group (LSE:ANCR) Headlines

No Headlines